Cargando…

Piloting a generic cancer consumer quality index in six European countries

BACKGROUND: Accounting for patients’ perspective has become increasingly important. Based on the Consumer Quality Index method (founded on Consumer Assessment of Healthcare Providers and Systems) a questionnaire was recently developed for Dutch cancer patients. As a next step, this study aimed to ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Wind, Anke, Roeling, Mark Patrick, Heerink, Jana, Sixma, Herman, Presti, Pietro, Lombardo, Claudio, van Harten, Wim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010728/
https://www.ncbi.nlm.nih.gov/pubmed/27589989
http://dx.doi.org/10.1186/s12885-016-2752-9
_version_ 1782451726695006208
author Wind, Anke
Roeling, Mark Patrick
Heerink, Jana
Sixma, Herman
Presti, Pietro
Lombardo, Claudio
van Harten, Wim
author_facet Wind, Anke
Roeling, Mark Patrick
Heerink, Jana
Sixma, Herman
Presti, Pietro
Lombardo, Claudio
van Harten, Wim
author_sort Wind, Anke
collection PubMed
description BACKGROUND: Accounting for patients’ perspective has become increasingly important. Based on the Consumer Quality Index method (founded on Consumer Assessment of Healthcare Providers and Systems) a questionnaire was recently developed for Dutch cancer patients. As a next step, this study aimed to adapt and pilot this questionnaire for international comparison of cancer patients experience and satisfaction with care in six European countries. METHOD: The Consumer Quality Index was translated into the local language at the participating pilot sites using cross-translation. A minimum of 100 patients per site were surveyed through convenience sampling. Data from seven pilot sites in six countries was collected through an online and paper-based survey. Internal consistency was tested by calculating Cronbach’s alpha and validity by means of cognitive interviews. Demographic factors were compared as possible influencing factors. RESULTS: A total of 698 patients from six European countries filled the questionnaire. Cronbach’s alpha was good or satisfactory in 8 out of 10 categories. Patient satisfaction significantly differed between the countries. We observed no difference in patient satisfaction for age, gender, education, and tumor type, but satisfaction was significantly higher in patients with a higher level of activation. CONCLUSION: This European Cancer Consumer Quality Index(ECCQI) showed promising scores on internal consistency (reliability) and a good internal validity. The ECCQI is to our knowledge the first to measure and compare experiences and satisfaction of cancer patients on an international level, it may enable healthcare providers to improve the quality of cancer care. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-016-2752-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5010728
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50107282016-09-04 Piloting a generic cancer consumer quality index in six European countries Wind, Anke Roeling, Mark Patrick Heerink, Jana Sixma, Herman Presti, Pietro Lombardo, Claudio van Harten, Wim BMC Cancer Research Article BACKGROUND: Accounting for patients’ perspective has become increasingly important. Based on the Consumer Quality Index method (founded on Consumer Assessment of Healthcare Providers and Systems) a questionnaire was recently developed for Dutch cancer patients. As a next step, this study aimed to adapt and pilot this questionnaire for international comparison of cancer patients experience and satisfaction with care in six European countries. METHOD: The Consumer Quality Index was translated into the local language at the participating pilot sites using cross-translation. A minimum of 100 patients per site were surveyed through convenience sampling. Data from seven pilot sites in six countries was collected through an online and paper-based survey. Internal consistency was tested by calculating Cronbach’s alpha and validity by means of cognitive interviews. Demographic factors were compared as possible influencing factors. RESULTS: A total of 698 patients from six European countries filled the questionnaire. Cronbach’s alpha was good or satisfactory in 8 out of 10 categories. Patient satisfaction significantly differed between the countries. We observed no difference in patient satisfaction for age, gender, education, and tumor type, but satisfaction was significantly higher in patients with a higher level of activation. CONCLUSION: This European Cancer Consumer Quality Index(ECCQI) showed promising scores on internal consistency (reliability) and a good internal validity. The ECCQI is to our knowledge the first to measure and compare experiences and satisfaction of cancer patients on an international level, it may enable healthcare providers to improve the quality of cancer care. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-016-2752-9) contains supplementary material, which is available to authorized users. BioMed Central 2016-09-02 /pmc/articles/PMC5010728/ /pubmed/27589989 http://dx.doi.org/10.1186/s12885-016-2752-9 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Wind, Anke
Roeling, Mark Patrick
Heerink, Jana
Sixma, Herman
Presti, Pietro
Lombardo, Claudio
van Harten, Wim
Piloting a generic cancer consumer quality index in six European countries
title Piloting a generic cancer consumer quality index in six European countries
title_full Piloting a generic cancer consumer quality index in six European countries
title_fullStr Piloting a generic cancer consumer quality index in six European countries
title_full_unstemmed Piloting a generic cancer consumer quality index in six European countries
title_short Piloting a generic cancer consumer quality index in six European countries
title_sort piloting a generic cancer consumer quality index in six european countries
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010728/
https://www.ncbi.nlm.nih.gov/pubmed/27589989
http://dx.doi.org/10.1186/s12885-016-2752-9
work_keys_str_mv AT windanke pilotingagenericcancerconsumerqualityindexinsixeuropeancountries
AT roelingmarkpatrick pilotingagenericcancerconsumerqualityindexinsixeuropeancountries
AT heerinkjana pilotingagenericcancerconsumerqualityindexinsixeuropeancountries
AT sixmaherman pilotingagenericcancerconsumerqualityindexinsixeuropeancountries
AT prestipietro pilotingagenericcancerconsumerqualityindexinsixeuropeancountries
AT lombardoclaudio pilotingagenericcancerconsumerqualityindexinsixeuropeancountries
AT vanhartenwim pilotingagenericcancerconsumerqualityindexinsixeuropeancountries